Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity
- PMID: 8673927
- DOI: 10.1038/nm0796-800
Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity
Abstract
The presence of obesity increases the risk of thrombotic vascular diseases. The role of fat accumulation and its effect on plasminogen activator inhibitor-1 (PAI-1) levels was investigated in humans and animals. Plasma PAI-1 levels were closely correlated with visceral fat area but not with subcutaneous fat area in human subjects. PAI-1 mRNA was detected in both types of fat tissue in obese rats but increased only in visceral fat during the development of obesity. These data suggest that an enhanced expression of the PAI-1 gene in visceral fat may increase plasma levels and may have a role in the development of vascular disease in visceral obesity.
Similar articles
-
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.Diabetes. 2000 Aug;49(8):1374-80. doi: 10.2337/diabetes.49.8.1374. Diabetes. 2000. PMID: 10923640
-
Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease.Diabetes. 1997 May;46(5):860-7. doi: 10.2337/diab.46.5.860. Diabetes. 1997. PMID: 9133556
-
Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals.Thromb Haemost. 2000 Apr;83(4):545-8. Thromb Haemost. 2000. PMID: 10780314
-
The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels.Blood Rev. 2016 Nov;30(6):421-429. doi: 10.1016/j.blre.2016.05.002. Epub 2016 May 19. Blood Rev. 2016. PMID: 27233154 Review.
-
Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity.Intern Med. 1999 Feb;38(2):202-6. doi: 10.2169/internalmedicine.38.202. Intern Med. 1999. PMID: 10225688 Review.
Cited by
-
Mechanisms by which obesity regulates inflammation and anti-tumor immunity in cancer.Biochem Biophys Res Commun. 2024 Nov 12;733:150437. doi: 10.1016/j.bbrc.2024.150437. Epub 2024 Jul 23. Biochem Biophys Res Commun. 2024. PMID: 39074412 Review.
-
Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review).Mol Med Rep. 2024 Jun;29(6):95. doi: 10.3892/mmr.2024.13219. Epub 2024 Apr 12. Mol Med Rep. 2024. PMID: 38606791 Free PMC article. Review.
-
Association between Metabolic Score for Visceral Fat and the risk of hypertension in different ethnic groups: a prospective cohort study in Southwest China.Front Endocrinol (Lausanne). 2024 Mar 18;15:1302387. doi: 10.3389/fendo.2024.1302387. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38562413 Free PMC article.
-
Changes in fibrin clot properties in patients after Roux-en-Y gastric bypass surgery.Res Pract Thromb Haemost. 2024 Mar 1;8(2):102361. doi: 10.1016/j.rpth.2024.102361. eCollection 2024 Feb. Res Pract Thromb Haemost. 2024. PMID: 38545128 Free PMC article.
-
The Effect of an Innovative Combination of Bergamot Polyphenolic Fraction and Cynara cardunculus L. Extract on Weight Gain Reduction and Fat Browning in Obese Mice.Int J Mol Sci. 2023 Dec 22;25(1):191. doi: 10.3390/ijms25010191. Int J Mol Sci. 2023. PMID: 38203362 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous